Glaxosmithkline ADR Representing 2 Ord Shs
(NYSE: GSK)
+0.44
+0.84%
| Shares Outstanding | 2.46 Bil |
| Institutional Ownership (%) | 10.48 |
| Top 10 Institutions (%) | 5.80 |
| Mutual Fund Ownership (%) | 0.12 |
| 5%/Insider Ownership (%) | 1.00 |
| Float (%) | 99.00 |
| DESCRIPTION | # OF HOLDERS | SHARES |
|---|---|---|
| Total Positions | 637 | 258,009,548 |
| New Positions | 60 | 0 |
| Soldout Positions | 155 | 0 |
| Net Position Change | -40 | -4,351,483 |
| Buyers | 317 | 17,802,873 |
| Sellers | 357 | -22,154,356 |
| MUTUAL FUND | SHS HELD | SHS CHG | %CHG | $CHG* | %OUT | %PORT | RPT DATE |
|---|---|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 25,621,200 | -50,000 | -0.2 | 85,963,428 | 1 | 2.7 | 03-31-13 |
| Dodge & Cox International Stock Fund | 19,853,749 | 0 | 0 | 68,296,897 | 0.8 | 2.2 | 03-31-13 |
| Dodge & Cox Balanced Fund | 5,310,600 | -410,000 | -7.2 | 445,764 | 0.2 | 2.7 | 03-31-13 |
| Vanguard PRIMECAP Fund | 5,200,500 | -443,500 | -7.9 | -34,912,825 | 0.2 | 0.8 | 12-31-12 |
| Fidelity Series International Growth Fund | 4,694,568 | -250,000 | -5.1 | 5,281,814 | 0.2 | 2.3 | 03-31-13 |
| FMI Large Cap Fund | 4,458,000 | 75,000 | 1.7 | 18,595,770 | 0.2 | 3.1 | 03-31-13 |
| MainStay Large Cap Growth Fund | 3,747,600 | 0 | 0 | 2,098,656 | 0.2 | 0.9 | 02-28-13 |
| T. Rowe Price Overseas Stock Fund | 2,625,713 | -23,600 | -0.9 | 8,006,561 | 0.1 | 2.1 | 03-31-13 |
| T. Rowe Price International Growth & Income Fund | 2,367,171 | -204,600 | -8 | -750,894 | 0.1 | 1.7 | 03-31-13 |
| Vanguard Health Care Fund | 2,180,381 | -562,000 | -20.5 | -16,929,629 | 0.1 | 0.4 | 03-31-13 |
| Invesco Comstock Fund | 2,031,702 | -7,091 | -0.3 | 829,507 | 0.1 | 0.9 | 02-28-13 |
| Invesco Charter Fund | 1,417,000 | 0 | 0 | 793,520 | 0.1 | 1.1 | 02-28-13 |
| Principal Equity Income Fund | 1,275,302 | 25,294 | 2 | 5,486,569 | 0.1 | 1.3 | 03-31-13 |
| Fidelity Select Pharmaceuticals Portfolio | 1,198,400 | 155,000 | 14.9 | 10,860,346 | 0 | 5.9 | 03-31-13 |
| AllianzGI NFJ Dividend Interest & Premium Strategy Fund | 1,180,000 | 0 | 0 | 660,800 | 0 | 4.1 | 02-28-13 |
- *Category Headings:
- Shs Held - shares held at report date
- Shs Chg - position change within reporting period
- %Chg - % change
- $Chg - market value of the position change
- %Out - % of shares outstanding
- %Port - % Portfolio
- Rpt Date - report date
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.